EMMER GREEN SURGERY — All Prescriptions & Medications — Page 10
Practice Code: K81041 | READING, RG4 8RA
Showing results 451-500 of 571
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder preterm infant formula (0913111) | 20 | 32.0K | £517 | +25.6% ▲ |
| Tizanidine hydrochloride | 20 | 1,264 | £150 | -24.5% ▼ |
| Malathion | 20 | 3,750 | £353 | +213.1% ▲ |
| Other individually formulated bought in preparations | 20 | 429 | £191 | -38.8% ▼ |
| Ipratropium bromide | 19 | 364 | £152 | -33.9% ▼ |
| Mebendazole | 19 | 512 | £46 | +66.0% ▲ |
| Repaglinide | 19 | 2,700 | £183 | -21.4% ▼ |
| Vardenafil | 19 | 98 | £164 | +36.1% ▲ |
| Alprostadil | 19 | 68 | £1.0K | +11.1% ▲ |
| Tube feed 2 kcal/ml with fibre (0914011) | 19 | 570.0K | £13.7K | +79.2% ▲ |
| 19 | 168 | £2.8K | -46.8% ▼ | |
| Propylthiouracil | 18 | 2,296 | £221 | +43.2% ▲ |
| Bicalutamide | 18 | 910 | £56 | -44.4% ▼ |
| Clindamycin/tretinoin | 18 | 750 | £284 | +53.3% ▲ |
| 18 | 870 | £601 | +29.9% ▲ | |
| 18 | 4,650 | £521 | -53.8% ▼ | |
| Itraconazole | 17 | 955 | £491 | +26.7% ▲ |
| Raloxifene hydrochloride | 17 | 588 | £83 | +15.1% ▲ |
| Mupirocin | 17 | 93 | £125 | +44.8% ▲ |
| 17 | 220 | £179 | -33.1% ▼ | |
| 17 | 2,650 | £530 | -37.7% ▼ | |
| Propantheline bromide | 16 | 1,600 | £1.3K | +23.3% ▲ |
| Nitrazepam | 16 | 343 | £19 | -69.2% ▼ |
| Ofloxacin | 16 | 420 | £610 | +94.7% ▲ |
| Norethisterone | 16 | 2,436 | £58 | +14.4% ▲ |
| Tube feed 1.5 kcal/ml with fibre (0914021) | 16 | 281.5K | £7.7K | +39.7% ▲ |
| Pilocarpine hydrochloride | 16 | 2,548 | £1.2K | +48.9% ▲ |
| 16 | 670 | £2.0K | +91.0% ▲ | |
| 16 | 5,462 | £418 | -20.9% ▼ | |
| 16 | 230 | £141 | -62.9% ▼ | |
| 16 | 350 | £141 | -60.9% ▼ | |
| Budesonide | 15 | 895 | £984 | -4.3% ▼ |
| Formoterol fumarate | 15 | 15 | £354 | +4.6% ▲ |
| Aspirin | 15 | 525 | £101 | +52.6% ▲ |
| Levodopa/carbidopa/entacapone | 15 | 1,794 | £591 | -46.4% ▼ |
| Rivastigmine | 15 | 450 | £285 | -78.2% ▼ |
| Powder 6.7 kcal/g energy and protein fortifier (0913141) | 15 | 840 | £782 | +90.9% ▲ |
| Olmesartan medoxomil/hydrochlorothiazide | 14 | 392 | £233 | +41.2% ▲ |
| Lacidipine | 14 | 392 | £30 | -88.3% ▼ |
| Glycopyrronium/formoterol | 14 | 14 | £432 | -44.7% ▼ |
| Daridorexant | 14 | 420 | £559 | +7.1% ▲ |
| Oxcarbazepine | 14 | 812 | £558 | -49.9% ▼ |
| Amantadine hydrochloride | 14 | 1,344 | £344 | -49.7% ▼ |
| Ibandronic acid | 14 | 24 | £24 | -61.5% ▼ |
| Calcitriol | 14 | 1,486 | £260 | -10.3% ▼ |
| Atropine sulfate | 14 | 240 | £3.2K | +9.9% ▲ |
| Tafluprost | 14 | 630 | £256 | -24.5% ▼ |
| Acetic acid | 14 | 110 | £103 | +20.9% ▲ |
| 14 | 4,100 | £38 | -44.3% ▼ | |
| 14 | 38 | £218 | -49.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.